Clinical Study

Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana

Table 1

Characteristics of 233 HIV-infected children on highly active antiretroviral therapy (HAART) from 2004–2009, Accra, Ghana.

Characteristics 𝑁 (%)

Age category
 <1 year10 (4.3)
 1–5 years118 (51.0)
 >6 years105 (45.1)
Gender
 Female112 (48.1)
 Male121 (51.9)
Immune recovery
 No61 (26.2)
 Yes172 (73.8)
WHO immune classification
 No evidence of suppression31 (13.3)
 Evidence of moderate suppression80 (34.3)
 Sever suppression122 (52.4)
WHO clinical staging
 I33 (14.1)
 II53 (22.7)
 III106 (45.5)
 IV41 (17.6)
Previous TB diagnosis and treatment
 Yes119 (51.1)
 No114 (48.9)
Graduate of PMTCT program
 Yes3 (1.3)
 No203 (87.1)
 Do not know27 (11.6)
Mode of transmission
 Vertical199 (85.4)
 Indeterminate11 (4.7)
 Do not know23 (9.9)
Self report of adherence
 Poor13 (5.6)
 Good46 (19.8)
 Excellent144 (61.8)
 Unknown30 (12.9)
Parental HIV status
 Both parents HIV-positive28 (12.0)
 Only one parent HIV-positive128 (54.9)
 Both parents unknown status75 (32.2)
 Mother unknown and father HIV-negative2 (0.9)
Parental living status
 Both parents alive109 (46.8)
 One parent known alive79 (33.9)
 Both parents dead23 (9.9)
 Both parents unknown8 (3.4)
 One parent alive and other unknown14 (6.0)